Recruiting Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment NCT07045935 Conditions Adenoma, Brain Diseases, Central Nervous System Diseases, +14 more Locations University Hospital Basel, Dept. of Endocrinology, Metabolism & Diabetes — Basel, Switzerland View Trial Details
